HRT Financial’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-202,763
Closed -$80K 3673
2022
Q2
$80K Buy
202,763
+76,421
+60% +$34.1K ﹤0.01% 2467
2022
Q1
$79K Buy
+126,342
New +$97.3K ﹤0.01% 2700
2021
Q2
Sell
-507,560
Closed -$1.65M 3675
2021
Q1
$1.65M Buy
+507,560
New +$1.84M 0.02% 718
2019
Q4
Sell
-19,665
Closed -$158K 1758
2019
Q3
$158K Buy
19,665
+17,103
+668% +$233K 0.01% 1193
2019
Q2
$45K Buy
+2,562
New +$56.1K ﹤0.01% 701
2019
Q1
Sell
-6,894
Closed -$202K 840
2018
Q4
$202K Buy
+6,894
New +$313K 0.03% 485

Other funds holding ASXC

HRT Financial's ASXC Position: Q3 2022 in Review

HRT Financial sold out of Asensus Surgical, Inc. (ASXC) in Q3 2022, closing a stake of 202,763 shares — an estimated $80K sold.

HRT Financial first reported a position in ASXC in Q4 2018 and held it in 6 quarters. The position peaked at $1.65M in Q1 2021. 82 funds tracked by Wall St. Rank hold ASXC as of Q3 2022.

  • HRT Financial reported no remaining Asensus Surgical, Inc. position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 202,763 Asensus Surgical, Inc. shares in Q3 2022, an estimated $80K.
  • HRT Financial first reported a position in Asensus Surgical, Inc. in Q4 2018 and held it in 6 quarters.
  • HRT Financial's Asensus Surgical, Inc. position peaked at $1.65M in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.